Bacterial Meningitis : Epidemiology and Vaccination |
Autore | Stuart James M |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Descrizione fisica | 1 electronic resource (274 p.) |
Soggetto topico |
Research & information: general
Biology, life sciences |
Soggetto non controllato |
meningitis
child mortality neonatal sepsis global health global health estimates modelling Streptococcus pneumoniae Haemophilus influenzae Neisseria meningitidis bacterial meningitis S. pneumoniae N. meningitidis H. influenzae S. agalactiae conjugate vaccines post-vaccine surveillance vaccine Africa mathematical modelling susceptibility invasive bacterial infections complement genetic factors Streptococcus agalactiae group B streptococci capsule meningococcal group nongroupable meningococcal carriage invasive meningococcal disease meningococcal urethritis neonatal infections epidemiology antibiotic resistance etiologic diagnosis enterovirus group B Streptococcus neurological sequelae hearing loss seizure epilepsy hydrocephalus focal neurological deficit corticosteroid dexamethasone invasive pneumococcal disease pneumococcal conjugate vaccines serotypes vaccine impact pneumococcal meningitis serotype distribution PCV impact global meta-analysis surveillance meningococcus pneumococcus Hib group B streptococcus conjugate vaccine rapid diagnostic test national reference laboratory cerebrospinal fluid Niger Burkina Faso tuberculosis tuberculous meningitis TBM children impact of Hib conjugate vaccine Hia NTHi burden social and economic costs WHO meningitis roadmap disability |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Bacterial Meningitis |
Record Nr. | UNINA-9910557626103321 |
Stuart James M | ||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Updates in Management of SARS-CoV-2 Infection |
Autore | Flisiak Robert |
Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
Descrizione fisica | 1 electronic resource (198 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
COVID-19
SARS-CoV-2 interleukin-6 tocilizumab therapy coronavirus disease 2019 cytokines severity prognosis mortality kidney failure rapid diagnostic test antigen detection Cytomegalovirus co-infections critical care liver markers inflammation morbidity personalized medicine liver functional tests COVID-19 pneumonia meta-analysis trial sequential analysis children clinical presentation coronavirus disease 2019 (COVID-19) epidemiology severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) clinical outcome symptomatology pandemic angiotensin 1 receptor (AT1R) AT1R concentration angiotensin II symptoms' severity diagnosis artificial intelligence medical imaging systematic umbrella review methodological credibility PCR test COVID-19 diagnosis Charlson Comorbidities Index cluster analysis longitudinal cluster individualized management |
ISBN | 3-0365-5390-8 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910619470303321 |
Flisiak Robert | ||
MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|